SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-21-016470
Filing Date
2021-07-06
Accepted
2021-07-06 17:01:16
Documents
1
Period of Report
2021-07-05
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K cbli20210706c_8k.htm 8-K 24924
  Complete submission text file 0001437749-21-016470.txt   26119
Mailing Address 73 HIGH STREET BUFFALO NY 14203
Business Address 73 HIGH STREET BUFFALO NY 14203 (716) 849-6810
CLEVELAND BIOLABS INC (Filer) CIK: 0001318641 (see all company filings)

IRS No.: 200077155 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32954 | Film No.: 211074929
SIC: 2834 Pharmaceutical Preparations